Cargando…

Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p

The usage of doxorubicin is hampered by its life-threatening cardiotoxicity in clinical practice. Dexrazoxane is the only cardioprotective medicine approved by the FDA for preventing doxorubicin-induced cardiac toxicity. Nevertheless, the mechanism of dexrazoxane is incompletely understood. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xiaoxue, Ruan, Yang, Shen, Tao, Qiu, Quan, Yan, Mingjing, Sun, Shenghui, Dou, Lin, Huang, Xiuqing, Wang, Que, Zhang, Xiyue, Man, Yong, Tang, Weiqing, Jin, Zening, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071803/ https://www.ncbi.nlm.nih.gov/pubmed/32190669 http://dx.doi.org/10.1155/2020/5107193

Ejemplares similares

miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1
por: Yan, Mingjing, et al.
Publicado: (2022)

Cisplatin/dexrazoxane/doxorubicin: Neutropenia and thrombocytopenia: case report
Publicado: (2020)

Ferulic Acid Alleviates Oxidative Stress-Induced Cardiomyocyte Injury by the Regulation of miR-499-5p/p21 Signal Cascade
por: Sun, Shenghui, et al.
Publicado: (2021)

Polypeptide Globular Adiponectin Ameliorates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting Both Apoptosis and Necroptosis
por: Zhu, Kaiyi, et al.
Publicado: (2021)

Dexrazoxane preferentially mitigates doxorubicin cardiotoxicity in female children with sarcoma
por: Narayan, Hari K, et al.
Publicado: (2019)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017)

miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling
por: Wang, Que, et al.
Publicado: (2019)

Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice
por: Bosman, Matthias, et al.
Publicado: (2023)

Effect of Dexrazoxane and Amifostine on the Vertebral Bone Quality of Doxorubicin Treated Male Rats
por: Mwale, F, et al.
Publicado: (2008)

Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
por: Sargent, J M, et al.
Publicado: (2001)

Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity
por: Cao, Yuan, et al.
Publicado: (2016)

Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
por: Li, Jieli, et al.
Publicado: (2020)

Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice
por: Kropp, Jenna, et al.
Publicado: (2015)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2022)

Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
por: Deng, Shiwei, et al.
Publicado: (2014)

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2023)

Cardiac shock wave therapy protects cardiomyocytes from hypoxia-induced injury by modulating miR-210
por: Qiu, Quan, et al.
Publicado: (2020)

Overexpression of angiopoietin-1 reduces doxorubicin-induced apoptosis in cardiomyocytes
por: Ren, Danyang, et al.
Publicado: (2012)

Anthracycline extravasation injuries: management with dexrazoxane
por: Jordan, Karin, et al.
Publicado: (2009)

Scavenging Effects of Dexrazoxane on Free Radicals
por: Junjing, Zhang, et al.
Publicado: (2010)

GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
por: Wang, Yue, et al.
Publicado: (2018)

In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization
por: Mody, Hardik, et al.
Publicado: (2023)

Protective effect of miR378* on doxorubicin‐induced cardiomyocyte injury via calumenin
por: Wang, Yu, et al.
Publicado: (2018)

Dexrazoxane for the treatment of chemotherapy-related side effects
por: Langer, Seppo W
Publicado: (2014)

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
por: Tong, Zhongyi, et al.
Publicado: (2015)

Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
por: Popelová, O, et al.
Publicado: (2009)

Cardiac Aging: From Basic Research to Therapeutics
por: Yan, Mingjing, et al.
Publicado: (2021)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
por: Kopp, Lisa M., et al.
Publicado: (2019)

In vitro to clinical translation of combinatorial effects of doxorubicin and dexrazoxane in breast cancer: a mechanism-based pharmacokinetic/pharmacodynamic modeling approach
por: Mody, Hardik, et al.
Publicado: (2023)

Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
por: Choi, Hyoung Soo, et al.
Publicado: (2010)

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
por: Vachhani, Pankit, et al.
Publicado: (2017)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
por: Macedo, Ariane V.S., et al.
Publicado: (2019)

Hydroxytyrosol Prevents Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes
por: Sirangelo, Ivana, et al.
Publicado: (2022)

Development and Validation of New RP-HPLC Method for the Determination of Dexrazoxane
por: Basaveswara Rao, M. V., et al.
Publicado: (2012)

Efficacy of Dexrazoxane in Cardiac Protection in Pediatric Patients Treated With Anthracyclines
por: Rahimi, Parya, et al.
Publicado: (2023)

Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane
por: Maloney, S L, et al.
Publicado: (2009)

Dexrazoxane ameliorates radiation-induced heart disease in a rat model
por: Li, Long, et al.
Publicado: (2021)

Curcumin Downregulates Phosphate Carrier and Protects against Doxorubicin Induced Cardiomyocyte Apoptosis
por: Junkun, Lu, et al.
Publicado: (2016)

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
por: Zhao, Liqun, et al.
Publicado: (2017)

Endogenous Hydrogen Sulfide Persulfidates Caspase-3 at Cysteine 163 to Inhibit Doxorubicin-Induced Cardiomyocyte Apoptosis
por: Ye, Xiaoyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jq7n2pt35nnho91853q9s10rgj